While small molecules like nicotine or estrogen can be absorbed via a patch, GLP-1 molecules are roughly ten times larger than the limit for skin absorption
Patients should contact their GP or prescribing clinician if they experience: Severe or persistent cramps that do not respond to simple measures or significantly impact daily activities and sleep quality Frequent cramping occurring multiple times daily or nightly Associated symptoms such as muscle weakness, numbness, tingling, or changes in sensation, which may indicate neurological involvement Visible muscle changes including swelling, redness, tenderness, or asymmetry between legs Signs of dehydration such as dizziness, reduced urine output, dark urine, or confusion These features may indicate underlying conditions requiring investigation, such as significant electrolyte disturbances, peripheral neuropathy (particularly relevant in diabetes), peripheral arterial disease, or, rarely, more serious muscle disorders
Medications including H-2 receptors and proton pump inhibitors can also help
The hypothesized anti-inflammatory properties of these medications represent a theoretically attractive mechanism for lipedema management, given the inflammatory component of the condition
Semaglutide, manufactured by Novo Nordisk and sold under the brands Ozempic and Wegovy, as treatment for type 2 diabetes (T2D) and obesity, respectively, was one of the catalysts behind the growth of the GLP-1RA market
To maintain the safety and effectiveness of the drug, refrigerate it until youre ready to inject it for the first time